Advanced Cell Diagnostics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 143

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $325M

Advanced Cell Diagnostics General Information

Description

Operator of a biotechnology company intended to develop cell and tissue-based diagnostic tests for personalized medicine. The company offers cancer diagnostic tests including tests for breast cancer, circulating tumor cells and cervical cancer and serves pharmaceutical and biotech companies, physicians and patients, enabling clients to avail quality cell research services.

Contact Information

Website
www.acdbio.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 614 McKinley Place NorthEast
  • Minneapolis, MN 55413
  • United States
+1 (612)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 614 McKinley Place NorthEast
  • Minneapolis, MN 55413
  • United States
+1 (612)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Advanced Cell Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Aug-2016 $325M Completed Generating Revenue
4. Later Stage VC (Series C) 18-Jun-2015 Completed Generating Revenue
3. Grant 06-Oct-2014 Completed Generating Revenue
2. Later Stage VC (Series B1) 01-Nov-2012 $12M $17.4M Completed Generating Revenue
1. Early Stage VC (Series A) 02-Sep-2009 $5.4M $5.4M Completed Product Development
To view Advanced Cell Diagnostics’s complete valuation and funding history, request access »

Advanced Cell Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2
Series B1
Series A 6,005,338 $0.000100 $0.07 $0.9 $0.9 1x $0.9 22.26%
To view Advanced Cell Diagnostics’s complete cap table history, request access »

Advanced Cell Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to develop cell and tissue-based diagnostic tests for personalized medicine
Discovery Tools (Healthcare)
Minneapolis, MN
143 As of 2025

Cambridge, MA
 

Bergisch Gladbach, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Advanced Cell Diagnostics Competitors (31)

One of Advanced Cell Diagnostics’s 31 competitors is Ultivue, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ultivue Formerly VC-backed Cambridge, MA
Miltenyi Biotec Private Debt Financed Bergisch Gladbach, Germany
Adaptive Biotechnologies Formerly VC-backed Seattle, WA
Genomic Expression Venture Capital-Backed Beverly, MA
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD
You’re viewing 5 of 31 competitors. Get the full list »

Advanced Cell Diagnostics Patents

Advanced Cell Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026174310-A1 Systems and methods for detecting target nucleic acid binding Pending 17-Feb-2025
WO-2026085349-A1 Systems, methods, and kits for detecting nucleic acid modifications Pending 16-Oct-2024
WO-2026085350-A1 Systems, methods, and kits for detecting nucleic acid-protein interactions Pending 16-Oct-2024
WO-2026019825-A1 Detection of target-binding small regulatory oligonucleotides Pending 15-Jul-2024
EP-4630578-A1 Multiplexed detection of nucleic acid targets Pending 07-Dec-2022 C12Q1/682
To view Advanced Cell Diagnostics’s complete patent history, request access »

Advanced Cell Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Advanced Cell Diagnostics Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kenson Ventures Venture Capital Minority
Morningside Group Venture Capital Minority
New Leaf Venture Venture Capital Minority
Summit Partners PE/Buyout Minority
To view Advanced Cell Diagnostics’s complete investors history, request access »

Advanced Cell Diagnostics FAQs

  • When was Advanced Cell Diagnostics founded?

    Advanced Cell Diagnostics was founded in 2006.

  • Where is Advanced Cell Diagnostics headquartered?

    Advanced Cell Diagnostics is headquartered in Minneapolis, MN.

  • What is the size of Advanced Cell Diagnostics?

    Advanced Cell Diagnostics has 143 total employees.

  • What industry is Advanced Cell Diagnostics in?

    Advanced Cell Diagnostics’s primary industry is Discovery Tools (Healthcare).

  • Is Advanced Cell Diagnostics a private or public company?

    Advanced Cell Diagnostics is a Private company.

  • What is the current valuation of Advanced Cell Diagnostics?

    The current valuation of Advanced Cell Diagnostics is .

  • What is Advanced Cell Diagnostics’s current revenue?

    The current revenue for Advanced Cell Diagnostics is .

  • How much funding has Advanced Cell Diagnostics raised over time?

    Advanced Cell Diagnostics has raised $39.4M.

  • Who are Advanced Cell Diagnostics’s investors?

    Kenson Ventures, Morningside Group, New Leaf Venture, and Summit Partners have invested in Advanced Cell Diagnostics.

  • Who are Advanced Cell Diagnostics’s competitors?

    Ultivue, Miltenyi Biotec, Adaptive Biotechnologies, Genomic Expression, and Personal Genome Diagnostics are some of the 31 competitors of Advanced Cell Diagnostics.

  • When was Advanced Cell Diagnostics acquired?

    Advanced Cell Diagnostics was acquired on 01-Aug-2016.

  • Who acquired Advanced Cell Diagnostics?

    Advanced Cell Diagnostics was acquired by Bio-Techne.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process